DES Daughters and their Cancer Risk

Patti Neighmond reports, NPR newsmagazines All Things Considered

DES Daughters and their Cancer Risk
Patti Neighmond, Correspondent, Health Policy, Science Desk

Award-winning journalist Patti Neighmond is NPR’s health policy correspondent. Her reports air regularly on NPR newsmagazines All Things Considered, Morning Edition and Weekend Edition.

Patti reported about DES on August 08, 2006, following a “new” study showing that daughters of women who took the anti-miscarriage drug DES, a synthetic estrogen, have a higher risk of developing breast cancer after age 50.

Click here to listen to All Things Considered radio show.

Click here to read the story.

DES and Breast Cancer

More DES DiEthylStilbestrol Resources

Have your say! Share your views